Fasihul Khan

University of Nottingham — United Kingdom

Medicine · Health Sciences

20h-index2.2kcitations69works5.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Long-Term Effects of COVID-19(21), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis(19), COVID-19 Clinical Research Studies(15), Chronic Obstructive Pulmonary Disease (COPD) Research(8), Sarcoidosis and Beryllium Toxicity Research(7)

Publications53 total

Comprehensive characterisation of individuals with fibrotic interstitial lung disease: baseline insights from the INJUSTIS study
BMJ Open Respiratory Research·2026Open Access
P19 Seasonal patterns of interstitial lung disease hospitalisations in a UK tertiary care centre
2025
P254 Home spirometry monitoring as an adjunct to clinical care in patients with fibrotic interstitial lung diseases: findings from the REMOTE-ILD randomised controlled trial
2025
Usual interstitial pneumonia on CT: same pattern, different prognosis
Thorax·2025
Gender differences disparity in treatments for in Sarcoidosis from the British Thoracic Society (BTS) UK Interstitial Lung Disease (ILD) registry.
2025
Gender differences in idiopathic pulmonary fibrosis (IPF) from the British Thoracic Society (BTS) UK ILD registry.
2025
Cluster analysis to phenotype sarcoidosis using British Thoracic Registry data
2025
Ethnic differences in presentation and treatment of sarcoidosis from the British Thoracic Society (BTS) UK Interstitial Lung Disease (ILD) registry.
2025
Gender disparity in immunosuppression prescribing in progressive pulmonary fibrosis (PPF) patients from the British Thoracic Society (BTS) United Kingdom (UK) interstitial lung disease (ILD) registry
2025
Effect of comorbidities on mortality in IPF: Analysis from the British Thoracic Society (BTS) UK interstitial lung disease (ILD) registry.
2025
Fostering Adherence in Ramadan for Antifibrotic Medications (FAST-AIM) - A multicentre cross-sectional study
2025
Emergence of azithromycin and ciprofloxacin non-susceptible genotype 4.2.2 <i>S</i> . Typhi in Fiji
Antimicrobial Agents and Chemotherapy·2025Open Access
Comparison of AI and resident doctors in diagnosing and managing acute respiratory cases: a retrospective study
Future Healthcare Journal·2025Open Access
Effect of Calcium Channel Blockers on Lung Function in Placebo-treated Patients in Idiopathic Pulmonary Fibrosis Trials
American Journal of Respiratory and Critical Care Medicine·2025
Minimum important difference of shuttle walk tests in patients with interstitial lung disease following pulmonary rehabilitation
ERJ Open Research·2025· 2 citedOpen Access
P143 Real-world multicentre evaluation of liver function monitoring in patients with idiopathic or progressive pulmonary fibrosis receiving anti-fibrotic therapy in the United Kingdom
2024
P67 Phenotyping pulmonary sarcoidosis with CT descriptors using BTS ILD registry data
2024
POS0223 REAL WORLD USE AND OUTCOMES OF AVACOPAN FOR ANCA-ASSOCIATED VASCULITIS DIFFER FROM CLINICAL TRIALS: A MULTICENTRE UK COHORT STUDY
Annals of the Rheumatic Diseases·2024
P18 Focused longitudinal observational study to improve knowledge of COVID-19 (follow-COVID19)
2024Open Access
Residual Lung Abnormality Following COVID-19 Hospitalisation is Characterised by Epithelial Injury
SSRN Electronic Journal·2024Open Access
page 1 of 3Next →

Frequent Co-authors

Iain Stewart(18), Gísli Jenkins(16), Nazia Chaudhuri(11), Gauri Saini(10), Laura Fabbri(9), Paul Minnis(9), Karen A. Robinson(8), Marium Naqvi(8), Philip L. Molyneaux(7), Michael Gibbons(7), Lisa Spencer(7), Felix Chua(7), Clare Hodkinson(7), Peter M. George(6), Shaney Barratt(6), Pilar Rivera‐Ortega(6), Andrew Achaiah(6), Paul Beirne(5), Simon R. Johnson(5), Mark G. Jones(5)